FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060766 [Registered on: 26/12/2023] Trial Registered Prospectively
Last Modified On: 29/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Comparative evaluation of efficacy of Murivenna Tail Gudapurana as against Yashtimadhu Ghrita Gudapurana in the management of postoperative pain of Piles and Fissure in ano 
Scientific Title of Study   Comparative evaluation of efficacy of Murivenna Tail Gudapurana as against Yashtimadhu Ghrita Gudapurana in the management of postoperative pain of Haemorrhoids and Fissure in ano 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ayushi Gautam 
Designation  PG Scholar 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room Number 13 Shalya Tantra OPD Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hiraur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8805514157  
Fax    
Email  ayushigautam0416@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sheetal Asutkar 
Designation  Head of Department of Shalyatantra 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room Number 13 Shalya Tantra OPD Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hiraur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9766811974  
Fax    
Email  sheetalasutkar16@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sheetal Asutkar 
Designation  Head of Department of Shalyatantra 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Room Number 13 Shalya Tantra OPD Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hiraur Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9766811974  
Fax    
Email  sheetalasutkar16@gmail.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute of Higher Education And Research 
 
Primary Sponsor  
Name  Datta Meghe Institute of Higher Education And Research 
Address  Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ayushi Gautam  Mahatma Gandhi Ayurved College Hospital and Research Centre   Room Number 13 OPD Shalya Tantra Department Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Hirapur Wardha
Wardha
MAHARASHTRA 
8805514157

ayushigautam0416@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K642||Third degree hemorrhoids. Ayurveda Condition: ARSAH , (2) ICD-10 Condition:K643||Fourth degree hemorrhoids. Ayurveda Condition: ARSAH, (3) ICD-10 Condition:K602||Anal fissure, unspecified. Ayurveda Condition: PARIKARTIKA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Murivenna taila, Reference: NA, Route: Rectal, Dosage Form: Taila, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 14 Days, Reference: NA, Route: NA, Dosage Form: Taila, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Comparator ArmDrugClassical(1) Medicine Name: Yashtimadhu ghrita , Reference: Sushruta shamhita , Route: Rectal, Dosage Form: Ghrita, Dose: 20(ml), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 14 Days, Reference: No, Route: NA, Dosage Form: Ghrita, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients with age group of 20 yrs to 60 yrs.
2. Controlled Diabetes
3. Post-operative patients with clinical feature of fissure in ano and haemorrhoids will be
included after screening irrespective of sex, religion and socioeconomic status.
4. Haemorrhoid Grade 3 & 4 
 
ExclusionCriteria 
Details  1. Patients suffering with Carcinoma Rectum.
2. Patients undergone LASER anorectal surgery
3. Pregnant and lactating women.
4. Immuno-compromised patients like HIV positive, HbSAg and Tuberculosis patient.
5. Known cases of Anaemia, Anorectal Malignancy, Crohn’s disease, Ulcerative colitis. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Analgesic effect in post operative pain of Haemorrhoids and fissure in ano   14 days 
 
Secondary Outcome  
Outcome  TimePoints 
Wound Healing effect of Drug  28 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This study will be carried out on post operative cases of Haemorrhoids and Fissure in ano to see analgesic effect.
Murivenna Tail is widely used in South India for Anti-inflammatory, wound healing, Analgesic properties, etc. It’s use in the form of Gudapurana (anal instillation) in post-operative pain can decrease the use of NSAIDs, opioids, steroids.  
Close